SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-014269
Filing Date
2019-12-27
Accepted
2019-12-27 16:06:14
Documents
3
Period of Report
2019-12-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 31476
2 FIRST AMENDMENT TO EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND FR ndra_ex101.htm EX-10.1 12427
3 FIRST AMENDMENT TO EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN THE COMPANY AND MI ndra_ex102.htm EX-10.2 12528
  Complete submission text file 0001654954-19-014269.txt   57768
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 191313819
SIC: 3845 Electromedical & Electrotherapeutic Apparatus